NovaFerrum
Commercial- Indications
- Iron deficiency, Anemia
Company intelligence / Profile preview
Gensavis Pharmaceuticals
Greenville, South Carolina, United Statesgensavis.com ↗
- Ownership
- Private
- Employees
- ~1
- Development stage
- Commercial
01
Overview
NovaFerrum products have been clinically proven to be safe, effective, and well tolerated for the treatment of nutritional iron deficiency. The infant drops formulation underwent an FDA clinical trial demonstrating these outcomes. High compliance rates are attributed to improved palatability compared to other liquid irons.[3][4][5]
- Therapeutic areas
- Hematology
- Modalities
- Nutritional supplementsIron polysaccharide oral solutionsOral dropsDietary supplements
- Industry
- Food & Nutrition
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Gensavis Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Gensavis Pharmaceuticals.